We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Depomed Suit: FDA Wrongfully Denied Orphan-Drug Exclusivity
Depomed Suit: FDA Wrongfully Denied Orphan-Drug Exclusivity
September 28, 2012
Depomed is taking the FDA to court, claiming the agency violated federal laws and its own regulations when it denied the company’s orphan drug Gralise seven years of marketing exclusivity.